Related Experiment Video
Updated: Aug 6, 2026

Ultrasonic Assessment of Myocardial Microstructure
Published on: January 14, 2014
Homocysteine: a new cardiac risk factor?
1Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, USA.
Insights
Elevated homocysteine is a risk factor for coronary artery disease. Supplementing with folate may help reduce homocysteine levels in high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
Background:
- Elevated plasma homocysteine is a newly identified risk factor for coronary artery disease (CAD).
- Hyperhomocysteinemia may contribute to vascular damage through various mechanisms.
- Understanding homocysteine metabolism is crucial for cardiovascular health.
Purpose of the Study:
- To review the role of homocysteine in coronary artery disease.
- To examine secondary causes of elevated homocysteine.
- To evaluate the efficacy of B vitamin supplementation for hyperhomocysteinemia.
Main Methods:
- Literature review of studies on homocysteine metabolism and CAD.
- Analysis of clinical evidence linking hyperhomocysteinemia to cardiovascular risk.
- Review of data on B vitamin supplementation effects on homocysteine levels.
Main Results:
- Hyperhomocysteinemia is implicated as a significant risk factor for CAD.
- B vitamin supplementation, particularly folate, can lower homocysteine concentrations.
- Current evidence suggests a potential benefit of folate supplementation in high-risk individuals.
Conclusions:
- Folate supplementation (400 mcg) is recommended for patients with established CAD or high cardiovascular risk.
- This approach is considered safe and effective in the absence of definitive clinical trial data.
- Further prospective trials are needed to confirm the long-term benefits.
Abstract:
Elevated plasma homocysteine levels have recently been implicated as a new risk factor for coronary artery disease. In this article, homocysteine metabolism, secondary causes of elevated plasma homocysteine, and the potential mechanism of vascular damage in hyperhomocysteinemia are briefly reviewed. The current clinical evidence implicating hyperhomocysteinemia as a risk factor for coronary artery disease, as well as the data regarding the effects of B vitamin supplementation on homocysteine concentrations, are also reviewed. The current recommendation of the authors is to treat patients with known coronary artery disease or those who are considered to be at high risk for coronary artery disease with 400 microg of folate supplementation. Until prospective clinical trial data become available, this approach appears to be a safe and effective way to approach this patient population.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
05:57The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension II: Pathophysiology
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...